FDA Launches Unified Adverse Event Tracking System, Critics Cite Unresolved Transparency Issues Introduction The Food and Drug Administration (FDA) launched a new centralized database on Tuesday, March 10, aimed at improving the monitoring of side effects from drugs, vaccines and other regulated products. The FDA Adverse Event Monitoring System (AEMS) consolidates several legacy platforms, including the Vaccine Adverse Event Reporting System, into a single, modern interface. FDA Commissioner Dr. Marty Makary stated the previous systems were “outdated and fragmented and made important data difficult to access.” [1][2] According to the agency, AEMS will provide public access to real-time data updates, replacing quarterly…

Newswire

Features

The Latest